Literature DB >> 12154149

Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings.

David L Sultzer1, Stephen T Chen, Charles V Brown, Michael E Mahler, Jeffrey L Cummings, Charles H Hinkin, Mark A Mandelkern.   

Abstract

The authors measured subcortical hyperintensities (SH) on magnetic resonance images (MRI) in 18 patients with probable Alzheimer's disease and examined the relationships of SH severity with cortical metabolic function and clinical symptoms. Severity of SH was not correlated with absolute metabolic rates in cortical lobes. However, anterior SH severity was inversely correlated with frontal/ parietal metabolic ratios after covarying for cognitive impairment. SH severity in some areas was associated with the severity of global neuropsychiatric symptoms, but marked effects on individual symptoms were not apparent. The small sample size and multiple variables limit conclusions that can be drawn. These preliminary findings indicate that subcortical MRI hyperintensities may play a role in the pathophysiology and clinical expression of Alzheimer's disease.

Entities:  

Mesh:

Year:  2002        PMID: 12154149     DOI: 10.1176/jnp.14.3.262

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  3 in total

Review 1.  Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer's disease.

Authors:  Michael L Alosco; Scott M Hayes
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter.

Authors:  L Glodzik; A Kuceyeski; H Rusinek; W Tsui; L Mosconi; Y Li; R S Osorio; S Williams; C Randall; N Spector; P McHugh; J Murray; E Pirraglia; S Vallabhajosula; A Raj; M J de Leon
Journal:  Neuroimage       Date:  2014-07-04       Impact factor: 6.556

3.  Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.

Authors:  Beth Kuczynski; Bruce Reed; Dan Mungas; Michael Weiner; Helena C Chui; William Jagust
Journal:  Arch Neurol       Date:  2008-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.